Lead Product(s): Anti-TDP-43 antibody
Therapeutic Area: Neurology Product Name: Anti-TDP-43 antibody
Highest Development Status: Preclinical Product Type: Large molecule
Partner/Sponsor/Collaborator: AC Immune
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership November 09, 2020
The partnership focuses on developing AC Immune’s clinical antibody candidate to ensure it has high-affinity for TDP-43 and is capable of preventing the intercellular spread of toxic species.